Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bio Green Med Solution (BGMS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Bio Green Med Solution (BGMS) over the last 12 years, with Q3 2025 value amounting to 1224.69%.

  • Bio Green Med Solution's EBITDA Margin rose 205453100.0% to 1224.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 11324.69%, marking a year-over-year increase of 96699000.0%. This contributed to the annual value of 27916.28% for FY2024, which is 218560400.0% down from last year.
  • Bio Green Med Solution's EBITDA Margin amounted to 1224.69% in Q3 2025, which was up 205453100.0% from 21770.0% recorded in Q3 2024.
  • In the past 5 years, Bio Green Med Solution's EBITDA Margin ranged from a high of 1224.69% in Q3 2025 and a low of 91100.0% during Q2 2024
  • Moreover, its 3-year median value for EBITDA Margin was 17290.32% (2023), whereas its average is 27253.29%.
  • Data for Bio Green Med Solution's EBITDA Margin shows a peak YoY increase of 210112500bps (in 2024) and a maximum YoY decrease of -895104600bps (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Bio Green Med Solution's EBITDA Margin stood at 17290.32% in 2023, then dropped by -26bps to 21770.0% in 2024, then skyrocketed by 94bps to 1224.69% in 2025.
  • Its EBITDA Margin was 1224.69% in Q3 2025, compared to 21770.0% in Q3 2024 and 91100.0% in Q2 2024.